医学
曲妥珠单抗
肿瘤科
多西紫杉醇
帕妥珠单抗
内科学
化疗
转移性乳腺癌
肺癌
乳腺癌
作者
Julien Mazieres,Claire Lafitte,Charles Ricordel,Laurent Greillier,Elodie Negre,Gérard Zalcman,Charlotte Domblides,Jeannick Madelaine,Jaafar Bennouna,Céline Mascaux,Denis Moro-Sibilot,François Pinquie,Alexis B. Cortot,Josiane Otto,Jacques Cadranel,Alexandra Langlais,Franck Morin,Virginie Westeel,Benjamin Besse
摘要
Triple therapy with trastuzumab, pertuzumab, and docetaxel is feasible and effective for HER2-mutated pretreated advanced NSCLC. These results highlight the effectiveness of the HER2 antibody-based strategy, which should be considered for these patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
宇宙无敌大火龙
GingerF
大力的灵雁
Tttttttt
sherry
无极微光
大龙哥886
哈哈
乐观寻双lll
zzzz
友好的季节
ff
dd
细腻不二
甜栗栗子
热心的半烟
郑旭东
GPTea
eric888
小蘑菇
皖公网安备34019202002308
